5 Proven Working Capital Strategies for Savings
Successful Accounts Payable managers are increasingly focused on cash and income as well as cost. Studies show that working capital savings initiatives deliver as much as 10 times the value of AP automation alone. Increasingly, early payment programs, credit card rebates, and supply chain finance are the biggest drivers of Accounts Payable success.
Tradeshift is thrilled to have Bavelos Group president, Tom Glassanos, discuss 5 proven strategies for optimizing accounts payable for working capital savings.
You will learn about:
- The tremendous Working Capital savings opportunity in front of you
- The role of new cloud-based technologies
- How to get substantial results in as little as 100 days.
Tom Glassanos, Founder and President of Bavelos Group
Tom Glassanos is founder and President of the Bavelos Group. He is a payment industry veteran who has helped thousands of organizations improve cash and profitability through the use of innovative strategies for working capital. Tom is credited with key innovations such as “Dynamic Discounting” and “Buyer Initiated Payment (BIP)” cards, and has been recognized by Supply & Demand Chain Executive Magazine as a “Pro to Know” three times. Tom has built multiple successful companies, including AP automation pioneer, Xign Corporation. He has an MBA from Harvard.
Rinus Strydom, VP Solutions Consulting & Alliances at Tradeshift
At Tradeshift, Rinus is responsible for the company’s global solutions consulting team and commercial alliances. Rinus brings 15 years of best practices experience in B2B supply management through using, deploying, and marketing enterprise solutions. He does frequent speaking engagements, press interviews, and periodical articles. Prior to joining Tradeshift his roles included Chief Marketing Officer at Hubwoo, Vice President of Alliances at Ariba, and global evangelist at SAP as part of their first eCommerce launch in the late 90s. Prior to entering the software industry, Rinus held supply management roles in the biotech and discrete manufacturing sectors.